This Government Contract opportunity from Department Of Health And Human Services was posted on May 21, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Development of 3D Human Blood Brain Barrier Formation Assay
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Food and Drug Administration (FDA) plans to issue a sole source firm fixed price purchase order to MIMETAS B.V., located in Gaithersburg, Maryland, for the development of a 3D human blood-brain barrier formation assay. This procurement follows FAR Part 6.302-1(a)(2)(ii), indicating that MIMETAS B.V. is the only responsible source capable of fulfilling the agency’s specific requirement. The notice serves to inform the public of this anticipated award and is not a solicitation for competitive proposals. However, any interested party believing they can meet the stated requirements may submit a written capability statement by June 12, 2026, at 3:00 PM EST for consideration, although the government reserves the right to proceed with the sole source award if no other capable source is identified. The project is set under NAICS code 54171 and managed by the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services. The place of performance is Silver Spring, Maryland. Interested respondents should submit their capability statements via email to the contract specialist, Hilda Aryeh. The anticipated award is expected within approximately ten days following the notice unless the government determines otherwise based on received submissions. Additional details, including the statement of work, are provided in the attached documentation to the notice.
General Info
Agency
NAICS
Place of Performance
Silver Spring, MD, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
The Food and Drug Administration (FDA) intends to award a Sole Source Firm Fixed Price Purchase order to MIMETAS B.V. 704 Quince Orchard RD, Suite 260 Gaithersburg, Maryland 20878-1752.
In accordance with FAR Part 6.302-1 (a) (2)(ii) which states” Only one responsible source and no other supplies or services will satisfy agency requirement”.
The purpose of this notice is to inform the public that the Food and Drug Administration (FDA) anticipates issuing a Firm Fixed Price Purchase Order.
MINIMUM REQUIREMENTS:
See Attached Statement of Work
This notice is not a request for competitive proposals. However, any party that believes it can meet this requirement as stated herein may submit a written capability statement that clearly supports and demonstrates their ability to perform the requirement.
Capability statements must be received by the response date and time of this notice. Submissions will be reviewed to determine if they can meet the requirement. A determination by the Government to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government.
It is anticipated that an award will be issued to MIMETAS B.V. within approximately ten (10) days after the date of this notice unless the Government determines that any other organization has the capability to meet this requirement.
Response Date: June 12, 2026, by 3.00PM EST. Please email responses to Hilda Aryeh –hilda.aryeh@fda.hhs.gov.
Hilda Aryeh
Contract Specialist
